Finance

Senarai
ELV:NYSE
Elevance Health Inc
USD 378.36
+0.18%
(+0.68) 1H
USD 382.49
+1.09% (+4.13)
Prapasaran
Ditutup: 27 Jul, 4:00:02 PTG GMT-4  ·   USD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk ELV...
Buka
USD 378.80
Tinggi
USD 379.34
Rendah
USD 372.39
Permodalan Pasaran
81.91B
Purata volum
1.72J
Volum
114.00
tgi 52 mgu
USD 436.24
rdh 52 mgu
USD 273.71
Beta
0.67
Syer tertunggak
216.87J
Bilangan pekerja
97K
Buka
USD 378.80
Tinggi
USD 379.34
Rendah
USD 372.39
Permodalan Pasaran
81.91B
Purata volum
1.72J
Volum
114.00
tgi 52 mgu
USD 436.24
rdh 52 mgu
USD 273.71
Beta
0.67
Syer tertunggak
216.87J
Bilangan pekerja
97K
Cerita berita
Daripada sumber merentas web
Profil
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
Perihal Elevance Health Inc
CEOGail Koziara Boudreaux
Pekerja96.6K
Diasaskan1944
Ibu pejabatIndianapolis, Indiana, Amerika Syarikat
Sektor-
Laman webelevancehealth.com
Rating penganalisis
Berdasarkan 19 penganalisis yang memberikan rating saham kepada ELV dalam tempoh 3 bulan yang lalu
Beli
Beli
13
Pegang
6
Jual
0
Ramalan 12 bulan
Berdasarkan 19 penganalisis Wall Street yang menawarkan sasaran harga 12 bulan untuk ELV dalam tempoh 3 bulan yang lalu.
Tertinggi
Semasa USD 378.36
USD 498.00 (+31.62%)
Purata
USD 449.33 (+18.76%)
Terendah
USD 393.00 (+3.87%)
Penganalisis
Syor
Tindakan
Sasaran harga
Diunjurkan
Tarikh
Lance Wilkes
Bernstein
Buy
Maintained
USD 488.00
+29%
07/21/2026
Andrew Mok CFA
Barclays
Buy
Reiterated
USD 457.00
+20.8%
07/20/2026
Whit Mayo
Leerink Partners
Hold
Reiterated
USD 395.00
+4.4%
07/17/2026
Ryan Langston
TD Cowen
Buy
Reiterated
USD 465.00
+22.9%
07/17/2026
David Windley
Jefferies
Buy
Maintained
USD 450.00
+18.9%
07/16/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
USD 395.00
+4.4%
07/15/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
USD 404.00
+6.8%
07/17/2026
Ben Hendrix
RBC Capital
Hold
Maintained
USD 424.00
+12.1%
07/15/2026
Jason Cassorla
Guggenheim
Buy
Maintained
USD 455.00
+20.3%
07/15/2026
Michael Ha
Robert W. Baird
Hold
Maintained
USD 393.00
+3.9%
07/16/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
USD 460.00
+21.6%
07/16/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
USD 473.00
+25%
07/16/2026
Amit Daryanani
Evercore ISI
Hold
Maintained
-
-
07/15/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 475.00
+25.5%
07/16/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 470.00
+24.2%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
USD 450.00
+18.9%
07/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
USD 476.00
+25.8%
06/08/2026
A.J. Rice
UBS
Buy
Maintained
USD 460.00
+21.6%
05/22/2026
George Hill
Deutsche Bank
Buy
Upgraded
USD 498.00
+31.6%
05/20/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Upgraded
USD 360.00
-4.9%
05/19/2026
Laporan terakhir
15 Jul 2026
Tempoh fiskal
S2 2026
EPS / Anggaran (USD)
USD 7.45 / USD 6.21
+19.99%melebihi
Hasil / Anggaran (USD)
50.47B / 48.63B
+3.80%melebihi
Panggilan persidangan pendapatan fiskal Suku Ke-2 2026
Menunggu panggilan persidangan pendapatan
Sekilas pandang
Cerapan daripada berita dan laporan terkini
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Penyata pendapatan
Hasil
Pendapatan bersih
Semua nilai dalam USD
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
50.71B
49.75B
50.18B
50.47B
Kos barangan yang dijual
38.14B
38.06B
35.62B
37.02B
Kos hasil
38.14B
38.06B
35.62B
37.02B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
10.65B
10.75B
11.79B
11.04B
Belanja kendalian
10.81B
10.92B
11.90B
11.15B
Jumlah belanja kendalian
48.95B
48.98B
47.52B
48.17B
Pendapatan kendalian
1.76B
766.00J
2.66B
2.30B
Pendapatan bukan kendalian lain
-
-
-
-
EBT termasuk item luar biasa
1.41B
215.00J
2.30B
1.94B
EBT tidak termasuk item luar biasa
1.41B
399.00J
2.30B
1.94B
Belanja cukai pendapatan
219.00J
-331.00J
544.00J
483.00J
Kadar cukai berkesan
15.58%
-153.95%
23.61%
24.94%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
1.19B
547.00J
1.76B
1.46B
Margin untung bersih
2.34%
1.10%
3.52%
2.90%
Perolehan bagi setiap syer
6.03
3.33
12.58
7.45
Pendapatan faedah dan pelaburan
-
-
-
-
Belanja faedah
-351.00J
-367.00J
-357.00J
-364.00J
Belanja faedah bersih
-351.00J
-367.00J
-357.00J
-364.00J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
2.14B
1.17B
3.02B
2.67B
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Transaksi orang dalam
Data transaksi orang dalam diperoleh daripada sumber pihak ketiga. Ketahui lebih lanjut
Orang dalam
Jawatan
Jenis
Tarikh
Saham
Jumlah
Halaman 1
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian

Penyelidikan

Apakah perkara yang anda fikirkan?
Apakah yang berlaku dengan pasaran hari ini?
Terokai perkara yang boleh dilakukan
Buat portfolio
Buat tugasan
Deep Search
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian